Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease Prophylaxis.

about

Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease Prophylaxis.

Item

http://www.wikidata.org/entity/Q48622749

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pharmacodynamic Monitoring Pre ...... rsus-Host Disease Prophylaxis.

@en

Pharmacodynamic Monitoring Pre ...... rsus-Host Disease Prophylaxis.

@nl

type

Item

label

Pharmacodynamic Monitoring Pre ...... rsus-Host Disease Prophylaxis.

@en

Pharmacodynamic Monitoring Pre ...... rsus-Host Disease Prophylaxis.

@nl

prefLabel

Pharmacodynamic Monitoring Pre ...... rsus-Host Disease Prophylaxis.

@en

Pharmacodynamic Monitoring Pre ...... rsus-Host Disease Prophylaxis.

@nl

P1476

Pharmacodynamic Monitoring Pre ...... rsus-Host Disease Prophylaxis.

@en

P2093

Alex Ganetsky

http://www.w3.org/2001/XMLSchema#string

Austin P Huffman

http://www.w3.org/2001/XMLSchema#string

David L Porter

http://www.w3.org/2001/XMLSchema#string

Lee P Richman

http://www.w3.org/2001/XMLSchema#string

Lisa Crisalli

http://www.w3.org/2001/XMLSchema#string

Robert H Vonderheide

http://www.w3.org/2001/XMLSchema#string

P2860

Leukocyte migration and graft-versus-host disease.

CCR5 expression on cells from HLA-matched unrelated marrow donors and graft-versus-host disease

Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation.

An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.

Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning.

Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease.

Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.

Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal

Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation

Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity.

P304

594-599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2017.10.028

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ran Reshef

P577

2017-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29061535

http://www.w3.org/2001/XMLSchema#string

P932

5826857

http://www.w3.org/2001/XMLSchema#string